Zevotek (Pinksheets: ZVTK) $0.014. Announced Wednesday after market close the completion of an overseas marketing and sales agreement. The sales agreement shall cover the territories of Germany, Austria, Switzerland, Slovakia, Hungry, Liechtenstein, Romania, Poland and the Czech Republic.
This marks a major venture into the European market for Zevotek. With an infomercial being broadcast into multiple countries and put into several different languages it has more depth then previous given to our products then in earlier sales deals. With their vast experience in the As Seen on TV market we felt this was the best opportunity to gain market share at this juncture.
The agreement calls for 60,000 bulbs over a 12-month period as the foundation of the marketing agreement. As needed, our European partner, in this deal can increase their orders to meet demand. The number of bulbs this deal calls for is only a starting point as we feel that the company Zevotek has chosen to work with, has a strong track record, and will be able to help us gain a foothold in the increasing market of energy efficient lighting. Discussions on the nightlight product were tabled at this time as they have prepared only the standard bulbs infomercial.
What They Do: Zevotek, Inc. plans to market and sell independently a range of distinct and independent lines of home care and household products.
Taiwan Semiconductor (NYSE: TSM) $10.08. Today announced consolidated revenue of NT$39.5 billion, net income of NT$1.56 billion, and diluted earnings per share of NT$0.06 (US$0.01 per ADS unit) for the first quarter ended March 31, 2009. Year-over-year, first quarter revenue decreased 54.8% while net income and diluted EPS decreased 94.5% and 94.4%, respectively. Compared to fourth quarter of 2008, first quarter results represent a 38.8% decrease in revenue, and a decrease of 87.5% in net income and in diluted EPS. All figures were prepared in accordance with R.O.C. GAAP on a consolidated basis.
What They Do: TSMC is the world's largest dedicated semiconductor foundry, providing the industry's leading process technology and the foundry's largest portfolio of process-proven libraries, IPs, design tools and reference flows.
Lockheed Martin (NYSE: LMT) $79.08. Announced today that The Department of Energy (DOE) has selected a team led by to manage and operate the new Mission Support Contract at its Hanford site in south central Washington State. The latest DOE determination was made following a protest lodged by a competing bidder and a review last fall by the Government Accountability Office.
With a total program value of $3.059 billion over a 10-year period, the contract includes a five-year base contract period and options to extend it to an additional five years. Lockheed Martin is joined in the limited liability company, Mission Support Alliance (MSA) by partners Jacobs Engineering Group, Inc., and Wackenhut Services, Inc. They will also be supported by several small teammates. MSA LLC had been notified in September, 2008, that it had won the contract.
What They Do: Lockheed Martin is a global security company that employs about 146,000 people worldwide and is principally engaged in the research, design, development, manufacture, integration and sustainment of advanced technology systems, products and services.
Medicis (NYSE: MRX) $13.57. Today announced along with Ipsen (Euronext:IPN) that the U.S. Food and Drug Administration’s (FDA) approval of the Biologics License Application (BLA) for DYSPORTTM (abobotulinumtoxinA), an acetylcholine release inhibitor and a neuromuscular blocking agent. The approval includes two separate indications, the treatment of cervical dystonia in adults to reduce the severity of abnormal head position and neck pain, and the temporary improvement in the appearance of moderate to severe glabellar lines in adults younger than 65 years of age.
What They Do: Medicis is the leading independent specialty pharmaceutical company in the United States focusing primarily on the treatment of dermatological and aesthetic conditions.
SmallCapReview.com is not a registered investment advisor or broker/dealer. No investor should assume that reliance on the views, opinions or recommendations contained herein will produce profitable results. Nothing within our site should be construed as an offer or solicitation to buy or sell products or securities. The companies we profile may lack an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. SmallCapReview.com may hold positions in securities mentioned herein, and may make purchases or sales in such securities featured on our website or within our reports. SmallCapReview has been compensated three thousand five hundred dollars by a third party Green Horseshoe for its efforts in profiling Zevotek Inc. SmallCapReview may decide to purchase or sell shares on a voluntary basis in the open market before, during or after the profiling period of this report.
